Similarly, a Zambian study on participants with early KS, to evaluate the longitudinal response to KS treatment with ART alone, found that HIV-1 viremia and CD4 count before and after treatment also did not differentiate KS responders from non-responders (Ngalamika et al., in submission). The gene discussed is CD4; the disease is Kaposi's sarcoma.